Pharminent

Gene Therapy for Rare Diseases: Challenges and opportunities encountered

LONDON, March 21, 2017 /PRNewswire/ — Throughout the past decade, the orphan drug landscape has undergone a considerable amount of maturing. As a result, an increasing amount of orphan drugs are being approved, while pharma and biotech’s get closer to revealing new and innovative… http://www.prnewswire.com/news-releases/gene-therapy-for-rare-diseases-challenges-and-opportunities-encountered-300426352.html

Filed under: General